Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Molecumetics and Asahi enter anticoagulant collaboration

May 22, 1997

Ibex Technologies presents data on heparin neutralization agent

May 21, 1997

Selective thrombin inhibitors revealed by HMR

May 21, 1997

Searle describes antiplatelet agents

May 20, 1997

3-D describes potent and selective thrombin inhibitors

May 15, 1997

Factor Xa inhibitors from 3-D

May 15, 1997

Fibrinogen antagonists reported by Lilly/Cor Therapeutics

May 14, 1997

RPR receives FDA clearance for new indication of enoxaparin

May 13, 1997

Serine protease inhibitors described by 3-D

May 12, 1997

BMS and Sanofi seek U.S. and European approval for clopidogrel

May 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....